Audit of physical health monitoring in children and adolescents receiving antipsychotics in neurodevelopmental clinics in Northumberland

被引:11
作者
Gnanavel, Sundar [1 ]
Hussain, Sharafat [1 ]
机构
[1] Tyne & Wear NHS Fdn Trust, Child & Adolescent Mental Hlth Serv, Villa 9, Morpeth NE61 3BP, England
来源
WORLD JOURNAL OF PSYCHIATRY | 2018年 / 8卷 / 01期
关键词
Antipsychotic; Children; Physical health Guidelines; AUTISTIC DISORDER; SAFETY; RECOMMENDATIONS; SCHIZOPHRENIA; IRRITABILITY; ARIPIPRAZOLE; RISPERIDONE; BEHAVIOR; YOUTH;
D O I
10.5498/wjp.v8.i1.27
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
AIM To ascertain performance against the standards set by National Institute for Clinical Excellence (NICE) guidelines on physical health monitoring of thirty children and adolescents prescribed antipsychotics in neurodevelopmental clinics in Northumberland and identifying areas for improvement in practice. METHODS The audit involved a review of recorded documentation pertaining to physical health monitoring in patient electronic records pertaining to children and adolescents attending neurodevelopmental clinics in Northumberland prescribed antipsychotics. Clients were also contacted by telephone if relevant documentation could not be identified or retrieved to confirm the details. 32 case notes were perused of which 2 were excluded as they had refused to have venepuncture which was documented in the electronic records. RESULTS The overall audit results demonstrated partial compliance with NICE guidelines on physical health monitoring in children and adolescents prescribed antipsychotics. Bi-annual recording of height, weight, blood pressure, pulse rate and review of side effects was completed in 100% of subjects. However, annual monitoring for blood tests including liver function, renal function full blood count as well as biannual monitoring of serum prolactin, serum lipid profile was completed only in 56% of subjects. Comparative baseline characteristics between the two groups (compliant and non-compliant with guidelines) found no differences based on any socio-demographic or clinical variables. However, the proportion of patients in the group compliant to guidelines was higher in the age group of 12-17 years as compared to < 12 years (70.58% vs 38.46%), though not statistically significant (chi(2) = 1.236; P = 0.24). CONCLUSION Development of tailored and specific guidelines for physical health monitoring in children and adolescents prescribed antipsychotics taking into consideration clinical effectiveness and safety profile is likely to improve adherence rates.
引用
收藏
页码:27 / 32
页数:6
相关论文
共 19 条
  • [1] Cognitive effects of risperidone in children with autism and irritable behavior
    Aman, Michael G.
    Hollway, Jill A.
    McDougle, Christopher J.
    Scahill, Lawrence
    Tierney, Elaine
    McCracken, James T.
    Arnold, L. Eugene
    Vitiello, Benedetto
    Ritz, Louise
    Gavaletz, Allison
    Cronin, Pegeen
    Swiezy, Naomi
    Wheeler, Courtney
    Koenig, Kathleen
    Ghuman, Jaswinder K.
    Pose, David J.
    [J]. JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2008, 18 (03) : 227 - 236
  • [2] American Academy of Child and Adolescent Psychiatry, PRACT PAR US AT ANT PRACT PAR US AT ANT
  • [3] [Anonymous], NICE TECHN APPR GUID
  • [4] Antipsychotic Prescription in Children and Adolescents An Analysis of Data From a German Statutory Health Insurance Company From 2005 to 2012
    Bachmann, Christian J.
    Lempp, Thomas
    Glaeske, Gerd
    Hoffmann, Falk
    [J]. DEUTSCHES ARZTEBLATT INTERNATIONAL, 2014, 111 (03): : 25 - +
  • [5] Findling RL, 2008, J CLIN PSYCHIAT, V69, P9
  • [6] A Randomized Controlled Trial Investigating the Safety and Efficacy of Aripiprazole in the Long-Term Maintenance Treatment of Pediatric Patients With Irritability Associated With Autistic Disorder
    Findling, Robert L.
    Mankoski, Raymond
    Timko, Karen
    Lears, Katherine
    McCartney, Theresa
    McQuade, Robert D.
    Eudicone, James M.
    Amatniek, Joan
    Marcus, Ronald N.
    Sheehan, John J.
    [J]. JOURNAL OF CLINICAL PSYCHIATRY, 2014, 75 (01) : 22 - 30
  • [7] Hall Ian, 2016, BMJ Qual Improv Rep, V5, DOI 10.1136/bmjquality.u209539.w3933
  • [8] Prevalence and Predictors of Lipid and Glucose Monitoring in Commercially Insured Patients Treated With Second-Generation Antipsychotic Agents
    Haupt, Dan W.
    Rosenblatt, Lisa C.
    Kim, Edward
    Baker, Ross A.
    Whitehead, Richard
    Newcomer, John W.
    [J]. AMERICAN JOURNAL OF PSYCHIATRY, 2009, 166 (03) : 345 - 353
  • [9] Case series: Spectrum of neuroleptic-induced movement disorders and extrapyramidal side effects in childhood-onset schizophrenia
    Kumra, S
    Jacobsen, LK
    Lenane, M
    Smith, A
    Lee, P
    Malanga, CJ
    Karp, BI
    Hamburger, S
    Rapoport, JL
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 1998, 37 (02) : 221 - 227
  • [10] Drug monitoring in child and adolescent psychiatry for improved efficacy and safety of psychopharmacotherapy
    Mehler-Wex C.
    Kölch M.
    Kirchheiner J.
    Antony G.
    Fegert J.M.
    Gerlach M.
    [J]. Child and Adolescent Psychiatry and Mental Health, 3 (1)